학술논문
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10970142